Mass spectrometry in structural and stereochemical problems. CCXXX. Preparation of 5.alpha.,20.alpha. and 5.alpha.,17.alpha.,20.alpha.-cholestane-3.beta.,6.alpha.-diol. Electron impact induced fragmentation of steroidal .DELTA.17(20), .DELTA.20(21) and .DELTA.20(22) olefins
METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER
申请人:Haggerty Timothy J.
公开号:US20140335050A1
公开(公告)日:2014-11-13
The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer.
Novel oxysterols activate the Hedgehog pathway and induce osteogenesis
作者:Frank Stappenbeck、Wei Xiao、Matt Epperson、Mariko Riley、Aaron Priest、Danwen Huang、KhanhLinh Nguyen、Michael E. Jung、R. Scott Thies、Francine Farouz
DOI:10.1016/j.bmcl.2012.07.073
日期:2012.9
Localized induction of bone formation is essential during orthopedic procedures that involve skeletal repair, such as surgical treatment of non-union bone fractures and degenerative disk disease. Herein we disclose the synthesis and biologicalevaluation of novel oxysterol derivatives designed as anabolicbone growth agents. Structure–activity relationship studies of oxysterol 4 have identified analogues
Mass spectrometry in structural and stereochemical problems. CCXXX. Preparation of 5.alpha.,20.alpha. and 5.alpha.,17.alpha.,20.alpha.-cholestane-3.beta.,6.alpha.-diol. Electron impact induced fragmentation of steroidal .DELTA.17(20), .DELTA.20(21) and .DELTA.20(22) olefins